Yao-Wei Wang

Yao-Wei Wang is a hepatic surgeon at Taipei Veterans General Hospital who has contributed to evidence on adjuvant antiviral therapy in hepatitis B-related HCC post-resection, demonstrating that nucleoside analog therapy reduces HCC recurrence. His surgical oncology research addresses optimal resection margin, anatomical versus non-anatomical hepatectomy, and perioperative strategies to minimize recurrence risk in resected HCC. He contributes to Asia-Pacific surgical oncology trials and guidelines for post-resection HCC management. Wang's work bridges hepatic surgery with adjuvant systemic therapy decision-making in HCC.